This report provides an overview of the IT market for the life sciences industry. Analysis includes market size & growth, forecasts (up to 2020), demand drivers, adoption & scope trends, key areas of investment, and implications for key stakeholders. The report features two special sections – the first focuses on the market opportunity (for service providers) and the second focuses on buyer’s maturity of digital adoption (for enterprises).

Key findings of the report include:

• Pharmatechnology and biotechnology are the most favorable opportunity segments
• R&D and supply chain lines of business will drive a higher share of sourcing decisions
• Application development and testing will witness fastest growth in services
• More than two-thirds of the current digital investments are focused on growth
• Contrary to popular belief, European pharma industry is ahead of United States in global digital investments
• Analytics and cloud are the drivers behind most LS digital deals

Key strategic questions addressed in this report include:

For service providers:

• What is the biggest opportunity segment in the global life sciences industry?
• Which service line (applications, testing, workplace services, etc.) will be the growth driver?
• What are buyers doing differently in their sourcing strategy?
• How to stay relevant in a highly competitive market?

For enterprises:

• How are peers in my segment investing in digital as an opportunity?
• Is digital investment about growth, efficiency, or both?
• Which value chain areas (R&D, clinical, supply chain, marketing, etc.) are garnering most investments from peers in the segment?
• Who are the service providers that can deliver on integrated sourcing?